Generated July 9, 2026 at 8:33 PM ET
· Covers July 9 trading day
· 10 of 140 ready 8-Ks selected
· AI-assisted overview
M&A activity dominated the day: Whitestone REIT (WSR) shareholders approved a $1.7B all-cash acquisition by Ares, and TruBridge (TBRG) was acquired by IKS Health for $26.25/share. Several companies faced Nasdaq compliance issues: Hydrofarm (HYFM) received a delisting determination for equity and bid price non-compliance, Bayview Acquisition (BAYA) was delisted after failing to close its merger, and both Prairie Operating (PROP) and Onfolio (ONFO) received bid price deficiency notices. Rackspace Technology (RXT) cut its FY26 revenue guidance by $150M and launched a $250M ATM, while Digital Brands Group (DBGI) forecasted a profitable Q3 with 300%-500% YoY revenue growth. Ionis Pharmaceuticals (IONS) reported that its eplontersen Phase 3 ATTR-CM trial missed the primary endpoint, though a monotherapy subgroup showed nominal benefit. MARA Holdings (MARA) acquired a 1,200-acre powered land site in Texas with up to 2 GW capacity for up to $600M in milestone payments.
HYFM
HYDROFARM HOLDINGS GROUP, INC.
regulatory
negative
materiality 0.85
July 9, 2026, 4:07 PM ET
Hydrofarm receives Nasdaq delisting determination for equity rule; also flagged for bid price non-compliance
- On July 2, 2026, Nasdaq determined Hydrofarm did not meet terms of extension to regain compliance with $2.5M minimum stockholders' equity rule.
- Company timely appealed on July 9, 2026, staying any further delisting action pending hearing.
- On July 6, 2026, Nasdaq notified Hydrofarm of non-compliance with minimum bid price of $1 per share for 30 consecutive business days.
M&A
positive
materiality 0.85
July 9, 2026, 8:09 AM ET
MARA acquires 1,200-acre powered land site in Texas with up to 2 GW capacity for $600M milestone payments
- Acquired from HIF USA LLC a site in Matagorda County, TX, with access to up to 2 GW of power capacity; closed July 2, 2026.
- Aggregate purchase price up to $600M in milestone payments tied to regulatory approvals, power authorization, and HPC lease.
- Site expected to provide initial 1 GW by Oct 2027 and up to 2 GW by Apr 2028; more than doubles MARA's potential power capacity to ~4.8 GW.
M&A
positive
materiality 1.00
July 9, 2026, 4:11 PM ET
Whitestone REIT shareholders approve $1.7B all-cash acquisition by Ares at $19.00/share
- Shareholders approved the merger with Ares; 37,039,161 votes for, 116,016 against.
- All-cash deal valued at approximately $1.7 billion; $19.00 per common share or unit.
- Acquisition expected to close on or about July 14, 2026, subject to remaining conditions.
M&A
neutral
materiality 1.00
July 9, 2026, 4:01 PM ET
TruBridge acquired by IKS Health for $26.25/share; merger completed July 9, 2026
- Shareholders received $26.25 per share in cash; stock ceased trading on Nasdaq.
- TruBridge becomes wholly owned subsidiary of IKS Health; board replaced by IKS appointees.
- Combined entity supports 2,000+ healthcare organizations and 150,000+ clinicians.
PROP
Prairie Operating Co.
regulatory
negative
materiality 0.65
July 9, 2026, 5:00 PM ET
Prairie Operating receives Nasdaq minimum bid price deficiency notice; 180 days to cure
- Nasdaq notified Prairie on July 2, 2026 that closing bid price was below $1.00 for 30 consecutive business days.
- Prairie has until December 29, 2026 to regain compliance by closing at or above $1.00 for 10 consecutive days.
- If not cured, Prairie may qualify for an additional 180-day period if it meets other listing standards.
ONFO
Onfolio Holdings, Inc
regulatory
negative
materiality 0.65
July 9, 2026, 4:10 PM ET
Onfolio receives Nasdaq bid price deficiency notice; 180 days to regain compliance
- Closing bid price of common stock below $1.00 for 30 consecutive business days as of July 2, 2026.
- Compliance period ends December 29, 2026; must close at $1.00+ for 10 consecutive days.
- If not cured, may be eligible for additional 180 days if meeting other listing standards.
RXT
Rackspace Technology, Inc.
earnings
negative
materiality 0.85
July 9, 2026, 8:13 AM ET
Rackspace cuts FY26 revenue guidance by $150M, launches $250M ATM, pivots to Enterprise AI
- Preliminary Q2 2026 revenue $641-649M; GAAP net loss $(91)-$(62)M; Adj. EBITDA $58-62M.
- FY26 revenue outlook lowered to $2.45-2.55B (from $2.6-2.7B); Adj. EBITDA lowered to $285-295M (from $305-315M).
- Entered $250M at-the-market equity offering with Goldman Sachs; AR facility extended to July 2029, capacity up to $350M.
DBGI
Digital Brands Group, Inc.
earnings
positive
materiality 0.85
July 9, 2026, 3:50 PM ET
DBGI forecasts profitable Q3 2026 with $8.5M-$11M revenue; AVO takes over lululemon in 1,000+ bookstores
- Q3 2026 revenue guidance $8.5M-$11M, positive net income; 300%-500% YoY revenue increase from $3.5M loss to break-even/positive.
- Collegiate expansion from 1 to 18 universities; government contract for first scale deployment across three cities.
- AVO brand partners with largest college bookstore chain (1,000+ locations), takes over lululemon's prime retail space.
BAYA
Bayview Acquisition Corp
other material
negative
materiality 0.85
July 9, 2026, 4:15 PM ET
Bayview Acquisition Corp receives Nasdaq delisting determination after failing to close Oabay merger by June 19 deadline
- Nasdaq delisting determination on July 2, 2026 for failing to close Oabay merger by June 19 deadline.
- Trading of BAYA, BAYAU, BAYAR securities suspended effective July 7, 2026; Form 25-NSE to be filed.
- Company intends to request review by Nasdaq Listing and Hearing Review Council within 15 days; no assurance of success.
IONS
IONIS PHARMACEUTICALS INC
other material
negative
materiality 0.85
July 9, 2026, 2:55 PM ET
Ionis eplontersen Phase 3 ATTR-CM trial misses primary endpoint; monotherapy subgroup shows nominal benefit
- CARDIO-TTRansform trial did not meet primary composite endpoint of CV mortality and recurrent CV events vs placebo at Week 140.
- In prespecified subgroup, eplontersen monotherapy showed nominally significant HR of 0.71 on the composite outcome.
- 57% of patients on stabilizer at baseline; no treatment effect observed in that subgroup.